Bank of New York Mellon’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-34,241
| Closed | -$629K | – | 4391 |
|
|
2020
Q4 | $629K | Sell |
34,241
-1,907
| -5% | -$35K | ﹤0.01% | 3498 |
|
|
2020
Q3 | $663K | Sell |
36,148
-1,248
| -3% | -$22.9K | ﹤0.01% | 3345 |
|
|
2020
Q2 | $560K | Buy |
37,396
+1,767
| +5% | +$26.5K | ﹤0.01% | 3419 |
|
|
2020
Q1 | $563K | Buy |
35,629
+709
| +2% | +$11.2K | ﹤0.01% | 3298 |
|
|
2019
Q4 | $567K | Buy |
34,920
+2,196
| +7% | +$35.7K | ﹤0.01% | 3531 |
|
|
2019
Q3 | $486K | Sell |
32,724
-5,960
| -15% | -$88.5K | ﹤0.01% | 3547 |
|
|
2019
Q2 | $640K | Sell |
38,684
-275
| -0.7% | -$4.55K | ﹤0.01% | 3484 |
|
|
2019
Q1 | $674K | Buy |
38,959
+1,102
| +3% | +$19.1K | ﹤0.01% | 3401 |
|
|
2018
Q4 | $669K | Buy |
37,857
+5,308
| +16% | +$93.8K | ﹤0.01% | 3323 |
|
|
2018
Q3 | $591K | Sell |
32,549
-2,030
| -6% | -$36.9K | ﹤0.01% | 3550 |
|
|
2018
Q2 | $676K | Buy |
34,579
+23,354
| +208% | +$457K | ﹤0.01% | 3465 |
|
|
2018
Q1 | $197K | Buy |
+11,225
| New | +$197K | ﹤0.01% | 3925 |
|
|
2017
Q2 | – | Sell |
-40,268
| Closed | -$475K | – | 4370 |
|
|
2017
Q1 | $475K | Buy |
40,268
+762
| +2% | +$8.99K | ﹤0.01% | 3575 |
|
|
2016
Q4 | $517K | Buy |
39,506
+2,641
| +7% | +$34.6K | ﹤0.01% | 3578 |
|
|
2016
Q3 | $534K | Sell |
36,865
-848
| -2% | -$12.3K | ﹤0.01% | 3501 |
|
|
2016
Q2 | $453K | Buy |
37,713
+4,868
| +15% | +$58.5K | ﹤0.01% | 3584 |
|
|
2016
Q1 | $613K | Buy |
32,845
+290
| +0.9% | +$5.41K | ﹤0.01% | 3335 |
|
|
2015
Q4 | $699K | Hold |
32,555
| – | – | ﹤0.01% | 3365 |
|
|
2015
Q3 | $551K | Sell |
32,555
-2,342
| -7% | -$39.6K | ﹤0.01% | 3510 |
|
|
2015
Q2 | $1.31M | Buy |
34,897
+28,269
| +427% | +$1.06M | ﹤0.01% | 3185 |
|
|
2015
Q1 | $209K | Buy |
+6,628
| New | +$209K | ﹤0.01% | 3885 |
|